Baird Maintains Neutral on HCA Healthcare, Lowers Price Target to $393

Benzinga Newsdesk www.benzinga.com Negative 80.6%

Neg 80.6% Neu 0% Pos 0%

Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $396 to $393.